{"title":"[Progress in diagnosis and treatment of neuroendocrine carcinoma of cervix].","authors":"H J Yu, D Hu, Y Sun","doi":"10.3760/cma.j.cn112141-20230626-00287","DOIUrl":null,"url":null,"abstract":"子宫颈神经内分泌癌(NECC)是一种高度侵袭、预后不良的少见子宫颈癌。NECC主要通过病理形态学及免疫组化法检测进行诊断,除了突触素、嗜铬素A、CD56和神经元特异性烯醇化酶等特异性神经内分泌标志物外,胰岛素瘤相关蛋白1也有望协助诊断。随着磁共振成像(MRI)检查在子宫颈癌分期中的应用得到肯定,影像学检查也可为鉴别诊断和分期提供帮助。目前,NECC无标准治疗方案,主要通过借鉴小细胞肺癌的治疗经验形成以综合治疗为主的治疗模式,靶向治疗、免疫治疗也显示出巨大的潜力,但在治疗方案的选择上仍存在众多争议。近年来,NECC的诊治相关研究取得了一系列新成果,本文就NECC的诊断和治疗进展作全面综述,对不同期别NECC提出了不同于其他病理类型子宫颈癌的综合治疗模式,以期为后续相关研究和临床实践提供参考。.","PeriodicalId":10050,"journal":{"name":"中华妇产科杂志","volume":"58 9","pages":"716-720"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华妇产科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112141-20230626-00287","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}